Bid­ding to be the go-to ge­nomics and da­ta part­ner for drug de­vel­op­ment, Sophia Ge­net­ics rais­es $100M

Ju­r­gi Cam­b­long has spent the last decade go­ing from mi­nor fund­ing round to mi­nor fund­ing round for his start­up, Sophia Ge­net­ics, adding hos­pi­tals in the UK, US, and Latin Amer­i­ca and ex­pand­ing the plat­form to han­dle more and more da­ta. Now, Cam­b­long says, the com­pa­ny has spread far enough and has now raised plen­ty of cash to clear one of its last hur­dles.

In the sixth and largest fund­ing round in their 9-year his­to­ry, Sophia Ge­net­ics has raised $110 mil­lion to push for­ward its AI-based plat­form for ge­net­ic med­i­cine with a re­newed fo­cus on tak­ing their es­tab­lished in­fra­struc­ture and us­ing it help bio­phar­ma col­lect ev­i­dence and de­sign tri­als. The round was led the Is­raeli firm aMoon and the Japan­ese firm Hi­tachi Ven­tures.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER